|
1
|
Fearon KC, Glass DJ and Guttridge DC:
Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell
Metab. 16:153–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Landen CN Jr, Birrer MJ and Sood AK: Early
events in the pathogenesis of epithelial ovarian cancer. J Clin
Oncol. 26:995–1005. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nieman KM, Kenny HA, Penicka CV, Ladanyi
A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB,
Hotamisligil GS, et al: Adipocytes promote ovarian cancer
metastasis and provide energy for rapid tumor growth. Nat Med.
17:1498–1503. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Daquinag AC, Amaya-Manzanares F,
Sirin O, Tseng C and Kolonin MG: Stromal progenitor cells from
endogenous adipose tissue contribute to pericytes and adipocytes
that populate the tumor microenvironment. Cancer Res. 72:5198–5208.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dirat B, Bochet L, Dabek M, Daviaud D,
Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S,
et al: Cancer-associated adipocytes exhibit an activated phenotype
and contribute to breast cancer invasion. Cancer Res. 71:2455–2465.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Michalek RD, Gerriets VA, Jacobs SR,
Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG and
Rathmell JC: Cutting edge: Distinct glycolytic and lipid oxidative
metabolic programs are essential for effector and regulatory CD4+ T
cell subsets. J Immunol. 186:3299–3303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang SC, Everts B, Ivanova Y, O'Sullivan
D, Nascimento M, Smith AM, Beatty W, Love-Gregory L, Lam WY,
O'Neill CM, et al: Cell-intrinsic lysosomal lipolysis is essential
for alternative activation of macrophages. Nat Immunol. 15:846–855.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pencheva N, Tran H, Buss C, Huh D,
Drobnjak M, Busam K and Tavazoie SF: Convergent multi-miRNA
targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis
and angiogenesis. Cell. 151:1068–1082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang L, Choi SH, Baek JS, Liu C, Almazan
F, Ulrich F, Wiesner P, Taleb A, Deer E, Pattison J, et al: Control
of angiogenesis by AIBP-mediated cholesterol efflux. Nature.
498:118–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ito Y, Azrolan N, O'Connell A, Walsh A and
Breslow JL: Hypertriglyceridemia as a result of human apo CIII gene
expression in transgenic mice. Science. 249:790–793. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsia SH, Connelly PW and Hegele RA:
Successful outcome in severe pregnancy-associated hyperlipemia: A
case report and literature review. Am J Med Sci. 309:213–218. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calza L, Manfredi R and Chiodo F:
Dyslipidaemia associated with antiretroviral therapy in
HIV-infected patients. J Antimicrob Chemother. 53:10–14. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Austin MA: Plasma triglyceride and
coronary heart disease. Arterioscler Thromb. 11:2–14. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reaven GM: Banting lecture 1988. Role of
insulin resistance in human disease. Diabetes. 37:1595–1607. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maher NG and Ramaswamykanive H: Use of
plasmapheresis in managing the diagnostic dilemma of symptomatic
hypertriglyceridemia. Case Rep Gastrointest Med.
2012:5013732012.PubMed/NCBI
|
|
16
|
Kyriakidis AV, Raitsiou B, Sakagianni A,
Harisopoulou V, Pyrgioti M, Panagopoulou A, Vasilakis N and
Lambropoulos S: Management of acute severe hyperlipidemic
pancreatitis. Digestion. 73:259–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Athyros VG, Giouleme OI, Nikolaidis NL,
Vasiliadis TV, Bouloukos VI, Kontopoulos AG and Eugenidis NP:
Long-term follow-up of patients with acute
hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol.
34:472–475. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yadav D and Pitchumoni CS: Issues in
hyperlipidemic pancreatitis. J Clin Gastroenterol. 36:54–62. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bollen TL, van Santvoort HC, Besselink MG,
van Leeuwen MS, Horvath KD, Freeny PC and Gooszen HG: Dutch Acute
Pancreatitis Study Group: The Atlanta Classification of acute
pancreatitis revisited. Br J Surg. 95:6–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Subramanian S and Chait A:
Hypertriglyceridemia secondary to obesity and diabetes. Biochim
Biophys Acta. 1821:819–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blumenschein GR Jr, Khuri FR, von Pawel J,
Gatzemeier U, Miller WH Jr, Jotte RM, Le Treut J, Sun SL, Zhang JK,
Dziewanowska ZE and Negro-Vilar A: Phase III trial comparing
carboplatin, paclitaxel, and bexarotene with carboplatin and
paclitaxel in chemotherapy-naive patients with advanced or
metastatic non-small-cell lung cancer: SPIRIT II. J Clin Oncol.
26:1879–1885. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gan SI, Edwards AL, Symonds CJ and Beck
PL: Hypertriglyceridemia-induced pancreatitis. A case-based review.
World J Gastroenterol. 12:7197–7202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jain P, Rai RR, Udawat H, Nijhawan S and
Mathur A: Insulin and heparin in treatment of
hypertriglyceridemia-induced pancreatitis. World J Gastroenterol.
13:2642–2643. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Markota A, Knehtl M, Sinkovic A, Ekart R,
Hojs R and Bevc S: Plasma exchange treatment for acute
hyperlipidemic pancreatitis with falsely low levels of serum
triglycerides- a case report. Transfus Apher Sci. 51:178–180. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Monib SM and El-Barbary HM: Acute
relapsing pancreatitis with pseudocyst formation due to sporadic
hypertriglyceridemic pancreatitis: A case report. Indian J Surg.
75:(Suppl 1). S340–S344. 2013. View Article : Google Scholar
|
